Illumina, Inc.

Illumina, Inc.
Company type	Public
Traded as	Nasdaq: ILMN; Nasdaq-100 component; S&P 400 component;
Industry	Biotechnology
Founded	1998; 26 years ago
Founders	David Walt; Larry Bock; John Stuelpnagel; Anthony Czarnik; Mark Chee;
Headquarters	San Diego, California, U.S.
Key people	Jacob Thaysen (CEO); Stephen P. MacMillan (Chairman);
Products	NovaSeq; HiSeq; MiSeq; MiniSeq; iSeq; NextSeq; iScan; COVIDSeq; VeriSeq; DRAGEN; Illumina Connected Analytics; TruSight Oncology;
Revenue	US$4.50 billion (2023)
Operating income	US$−1.1 billion (2023)
Net income	US$−1.2 billion (2023)
Total assets	US$10.1 billion (2023)
Total equity	US$5.75 billion (2023)
Number of employees	approx. 9,250 (2023)
Website	illumina.com
	Footnotes / references;

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.^[2]

Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.^[1]

^ ^a ^b "US SEC:Form 10-K Illumina, Inc". U.S. Securities and Exchange Commission. 16 February 2024. Archived from the original on 17 February 2024. Retrieved 17 February 2024.
^ Morrison, Mary E. (May 31, 2023). "At Illumina, Breaking DownBarriers to Democratize Genomics". Wall Street Journal. Deloitte. Archived from the original on November 8, 2023. Retrieved November 8, 2023.

[AR-1] "US SEC:Form 10-K Illumina, Inc". U.S. Securities and Exchange Commission. 16 February 2024. Archived from the original on 17 February 2024. Retrieved 17 February 2024.

[2] Morrison, Mary E. (May 31, 2023). "At Illumina, Breaking DownBarriers to Democratize Genomics". Wall Street Journal. Deloitte. Archived from the original on November 8, 2023. Retrieved November 8, 2023.

[1]

[2]